April 22, 2024

Bio-Europe 2025

Bio-Europe 2025

Europe’s premier partnering event

November 3–5, 2025 | Vienna, Austria

November 11–12, 2025 | Digital Partnering

BIO-Europe will host over 29,000 one-to-one meetings. The powerful partneringONE platform allows you to effortlessly and efficiently search for your most ideal partners. BIO-Europe will feature a distinguished lineup of speakers, including leading experts and visionaries from the biotech and pharma industries, who will take you on a journey of the past 30 years of experiences, partnerships and innovation and envision trends in the next 30 years to come.


BioRN Members get a 15 %  discount.

Registration Rates

EARLY BIRD:
by July 25
by Sept. 12 by Oct. 17 by Nov. 1 on-site DIGITAL PASS w/o on-site access
R&D Company, Investor, Government €       2.695,00  €        2.895,00  €   3.195,00  €   3.495,00  €   3.795,00  €        1.695,00
Biotech & Academics Pre-Revenue Offer TWO registrations for the price of ONE. Deadline to apply: Oct. 27
Service Provider  €       3.395,00  €        3.595,00  €   4.295,00  €   4.595,00  €   4.895,00  €        2.695,00
Young Innovator Rate €           795,00  €            995,00  €   1.195,00  €   1.195,00  €   3.795,00

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

Important: Those companies that have booked a stand participation via the German Pavilion will continue to receive their tickets at the lower R&D / Investor / Government rate. Registration information will be shared directly by the organizing company at a later date.


Please visit the German Pavilion @ BioEurope Fall 2025 in Vienna

Germany@BioEurope Wien 2025

register now

Our latest News

discover more
DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

The aim of the project is to use special quantitative MRI to visualize early changes in the intervertebral disc and enable timely treatment. Ultrashort echo time (UTE) MRI opens up completely new approaches to preventive imaging that are difficult or impossible to achieve with conventional MRI methods. Full text in German below. DFG fördert Heidelberger […]

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Researchers from Heidelberg University’s Medical Faculty, the German Cancer Research Center (DKFZ), and the National Center for Tumor Diseases (NCT) in Heidelberg have tested the use of targeted drugs in the initial treatment of newly diagnosed glioblastoma, an extremely aggressive brain tumor, in the multicenter study “NCT Neuro Master Match (N2M2)”. Of the five drugs […]

Global effort to sequence all life on Earth ramps up

Global effort to sequence all life on Earth ramps up

The Earth BioGenome Project is accelerating its efforts tenfold to sequence all life on Earth by 2035 Summary A global collaboration that includes experts at EMBL’s European Bioinformatics Institute (EMBL-EBI) has entered the second phase of its ambitious plan to sequence all 1.67 million known species on Earth by 2035.  The Earth BioGenome Project (EBP), a […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp